🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/11/2004 | 24,89 | 25,36 | 24,56 | 25,35 | +1,37% | 3,22% | 37.632.946 |
| 05/11/2004 | 25,46 | 25,67 | 24,80 | 25,01 | -3,00% | 3,41% | 52.761.874 |
| 04/11/2004 | 26,66 | 26,96 | 25,65 | 25,78 | -3,05% | 4,90% | 35.970.085 |
| 03/11/2004 | 26,34 | 26,62 | 25,67 | 26,59 | +3,99% | 3,62% | 51.887.842 |
| 02/11/2004 | 26,95 | 27,24 | 25,19 | 25,57 | -5,23% | 7,61% | 67.250.684 |
| 01/11/2004 | 28,00 | 28,44 | 26,71 | 26,98 | -9,68% | 6,17% | 69.787.997 |
| 29/10/2004 | 30,07 | 30,57 | 29,63 | 29,88 | -0,82% | 3,14% | 17.765.382 |
| 28/10/2004 | 29,72 | 30,22 | 29,69 | 30,12 | +1,12% | 1,77% | 10.244.095 |
| 27/10/2004 | 29,15 | 29,81 | 29,11 | 29,79 | +1,83% | 2,39% | 12.499.915 |
| 26/10/2004 | 29,08 | 29,26 | 28,85 | 29,26 | +0,56% | 1,41% | 13.229.009 |
| 25/10/2004 | 29,16 | 29,23 | 28,82 | 29,09 | -0,23% | 1,41% | 11.498.342 |
| 22/10/2004 | 29,68 | 29,82 | 29,10 | 29,16 | -2,24% | 2,41% | 14.164.034 |
| 21/10/2004 | 29,84 | 30,06 | 29,30 | 29,83 | -0,45% | 2,53% | 10.728.690 |
| 20/10/2004 | 29,73 | 30,04 | 29,68 | 29,96 | +0,77% | 1,22% | 16.312.120 |
| 19/10/2004 | 29,68 | 29,87 | 29,61 | 29,73 | +0,84% | 0,87% | 15.273.447 |
| 18/10/2004 | 28,91 | 29,59 | 28,91 | 29,48 | +1,31% | 2,34% | 13.306.456 |
| 15/10/2004 | 28,72 | 29,34 | 28,72 | 29,10 | +1,03% | 2,16% | 14.877.513 |
| 14/10/2004 | 28,91 | 29,15 | 28,76 | 28,81 | +0,40% | 1,35% | 14.542.886 |
| 13/10/2004 | 29,75 | 29,77 | 28,56 | 28,69 | -2,53% | 4,07% | 25.127.582 |
| 12/10/2004 | 29,13 | 29,58 | 28,90 | 29,44 | +0,36% | 2,33% | 18.004.850 |
| 11/10/2004 | 28,95 | 29,71 | 28,39 | 29,33 | +1,32% | 4,58% | 25.329.426 |
| 08/10/2004 | 29,39 | 29,69 | 28,95 | 28,95 | -2,07% | 2,53% | 23.479.811 |
| 07/10/2004 | 29,72 | 29,82 | 28,80 | 29,56 | -2,18% | 3,44% | 53.912.998 |
| 06/10/2004 | 31,60 | 31,64 | 30,21 | 30,22 | -5,26% | 4,53% | 50.767.111 |
| 05/10/2004 | 32,67 | 32,68 | 31,90 | 31,90 | -2,34% | 2,39% | 28.795.582 |
| 04/10/2004 | 32,70 | 32,75 | 32,19 | 32,66 | +2,76% | 1,72% | 37.088.196 |
| 01/10/2004 | 32,15 | 32,41 | 31,68 | 31,78 | +0,94% | 2,29% | 60.270.480 |
| 30/09/2004 | 31,87 | 32,46 | 30,97 | 31,49 | -26,78% | 4,67% | 151.976.244 |
| 29/09/2004 | 42,73 | 43,01 | 42,60 | 43,01 | +0,33% | 0,96% | 5.124.196 |
| 28/09/2004 | 42,63 | 43,26 | 42,46 | 42,86 | +1,03% | 1,88% | 6.111.936 |